AXION BIOSYSTEMS HOLDING UK LIMITED
Executive Summary
AXION BIOSYSTEMS HOLDING UK LIMITED shows a fragile financial condition characterized by minimal net assets and high current liabilities owed to group companies. While compliant with filings and audited cleanly, its liquidity position is strained. Strengthening equity and improving intra-group financing terms are key steps to enhance financial health.
View Full Analysis Report →Company Documents
Date | Description |
---|---|
15/01/2515 January 2025 | Confirmation statement made on 2024-12-23 with updates |
01/10/241 October 2024 | Accounts for a small company made up to 2023-12-31 |
07/06/247 June 2024 | Termination of appointment of James Ross as a director on 2024-01-31 |
07/06/247 June 2024 | Appointment of Julien Bradley as a director on 2024-01-31 |
09/01/249 January 2024 | Confirmation statement made on 2023-12-23 with updates |
22/09/2322 September 2023 | Accounts for a small company made up to 2022-12-31 |
30/08/2330 August 2023 | Appointment of Saad Sheikh as a director on 2023-08-10 |
30/08/2330 August 2023 | Registered office address changed from C/O Critchleys Llp Beaver House 23-38 Hythe Bridge Street Oxford Oxfordshire OX1 2EP United Kingdom to 8 King Edward Street Oxford OX1 4HL on 2023-08-30 |
30/08/2330 August 2023 | Termination of appointment of Nicole Stockli Mayer as a director on 2023-08-10 |
13/01/2313 January 2023 | Confirmation statement made on 2022-12-23 with no updates |
31/12/2231 December 2022 | Annual accounts for year ending 31 Dec 2022 |
23/12/2123 December 2021 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company